NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名：Promethazine 25mg/ml 1ml SDA - Box/25生产商：X-GENProduct Code: CP-5525-3NDC Code: 39822-5525-3
产品名称：TOBI PODHALER 上市时间：02/10/2023NDA/ANDA/BLA:201688持证商：MYLAN SPECIALITY LPNDC:49502-401-09,49502-401-57,49502-401-24说明书：https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201688s000lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/201688Orig1s000ltr.pdf
产品名称：OLANZAPINE上市时间：02/10/2023NDA/ANDA/BLA:76255持证商：DR REDDYS LABS LTDNDC:70518-1611-1,43598-164-10,70518-1764-0,55154-5896-0,71335-0714-4,71335-0714-5,70518-1535-0,70518-1605-0,43598-164-01,43598-166-30,55111-163-78,55111-163-01,70518-1635-0,70518-0110-0,55111-163-05,55111-163-30,71335-0714-1,43598...
产品名称：TOBRAMYCIN SULFATE上市时间：02/10/2023NDA/ANDA/BLA:62945持证商：WATSON LABS INCNDC:说明书：批准信：
产品名称：GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER上市时间：02/10/2023NDA/ANDA/BLA:62373持证商：BAXTER HLTHCARENDC:0338-0503-48,0338-0505-48,0338-0507-41,0338-0507-48,0338-0509-41,0338-0511-41说明书：批准信：
产品名称：TOBI 上市时间：02/10/2023NDA/ANDA/BLA:50753持证商：MYLAN SPECIALITY LPNDC:49502-345-73说明书：批准信：
产品名称：EPIPEN JR. 上市时间：02/10/2023NDA/ANDA/BLA:19430持证商：MYLAN SPECIALITY LPNDC:51662-1224-1,51662-1225-1,71872-7134-1,49502-500-92,49502-501-92,50090-4543-0,70518-1224-0,71872-7135-1,49502-101-02,49502-102-02,49502-500-02,49502-501-02说明书：批准信：
产品名称：EPIPEN E Z PEN 上市时间：02/10/2023NDA/ANDA/BLA:19430持证商：MYLAN SPECIALITY LPNDC:51662-1224-1,51662-1225-1,71872-7134-1,49502-500-92,49502-501-92,50090-4543-0,70518-1224-0,71872-7135-1,49502-101-02,49502-102-02,49502-500-02,49502-501-02说明书：批准信：
产品名称：EPIPEN 上市时间：02/10/2023NDA/ANDA/BLA:19430持证商：MYLAN SPECIALITY LPNDC:51662-1224-1,51662-1225-1,71872-7134-1,49502-500-92,49502-501-92,50090-4543-0,70518-1224-0,71872-7135-1,49502-101-02,49502-102-02,49502-500-02,49502-501-02说明书：批准信：
产品名称：EPI E Z PEN JR 上市时间：02/10/2023NDA/ANDA/BLA:19430持证商：MYLAN SPECIALITY LPNDC:51662-1224-1,51662-1225-1,71872-7134-1,49502-500-92,49502-501-92,50090-4543-0,70518-1224-0,71872-7135-1,49502-101-02,49502-102-02,49502-500-02,49502-501-02说明书：批准信：
产品名称：PANTOPRAZOLE SODIUM上市时间：02/09/2023NDA/ANDA/BLA:217416持证商：AJANTA PHARMA LTDNDC:27241-256-11,27241-256-38说明书：批准信：
